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Abstract
We are in the midst of a pandemic due to SARS-CoV-2. Pregnancy was identified among the risk factors for worse clinical outcomes in multiple studies. The optimal therapy in this
group of patients remains to be defined. Here, we present
the case of a 39-year-old Caucasian pregnant female at 31
weeks of gestation, who was treated successfully with hydroxychloroquine, azithromycin, remdesivir, prone therapy, and
cesarean delivery of a healthy baby while on mechanical ven-

tilation. She remained SARS-CoV-2-positive until the 39th
day of hospitalization. We discuss the pathophysiology of
the increased risk of infections during pregnancy and particularly the high risk of microthombosis and coagulopathy due
to COVID-19. Ultimately, the contribution of the medications
used to the favorable outcomes remains unknown; it is more
likely that the delivery helped to resolve the infection.

Introduction

In this article, we describe a case of a pregnant patient who developed ARDS with accelerated respiratory failure requiring intubation and further intensive
care unit (ICU) management. We hypothesize her disease process was accelerated by her pregnancy and outline her case and management here. Additionally, we
performed a literature review of available treatments
and compare those with the management strategies utilized in this patient

The world as we know it has changed with the SARSCoV-2 pandemic. The virus known to cause COVID-19
and has been particularly virulent, leading to a global
health crisis. COVID-19 primarily presents with respiratory compromise, often leading to acute respiratory distress syndrome (ARDS) and multi-organ failure. Multiple studies have postulated the role of thromboembolic events as a vital trigger for COVID-19 induced coagulopathy.[1] The pathogenesis of the disease
remains to be determined, however observational studies suggest the integral role of endothelial activation
and microthrombosis with disseminated organ damage
as the cause for increased morbidity and mortality.[2]
Some patient populations are noted to have a higher
predisposition to COVID-19 such as those with history
of asthma, chronic obstructive pulmonary disease, cardiovascular disease and pregnancy. Of note, pregnancy
itself is described as a pro-coagulant state. The progression and severity of COVID-19 is not yet well defined
or studied in the pregnant population.
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Case Description
The patient was a 39-year-old Caucasian female with a
past medical history of bicuspid aortic valve and type
1 myotonic dystrophy. She presented to the Emergency
Department (ED) at 31 weeks gestation with a two-day
history of cough, headache and fever. She had known
exposure to a COVID-19 positive individual prior to
presentation. The patient was discharged home due to
her mild symptoms and clinical stability. She was advised to return if symptoms worsened.
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Figure 1. Patchy areas of opacity seen within both lungs, left greater than right. Infection, including both viral and bacterial pneumonia is favored
over edema.

Four days later, the patient presented with worsening
shortness of breath and her vitals on presentation were
notable for a fever of 101.6 F with an oxygen saturation of 89% on room air. Chest X-ray and computed
tomography angiography of the chest showed bilateral
patchy infiltrates (Figure 1 and Figure 2). White blood
cell count was consistent with lymphopenia and a procalcitonin was elevated at 0.33. The patient was initially
admitted to the medical floor on 3L of oxygen via nasal
cannula. However, she decompensated quickly with an
arterial blood gas remarkable for a PaO2/FiO2 ratio of
142, consistent with moderately severe ARDS. As a result, she was transferred ICU, intubated and mechanically ventilated. The patient was started on ceftriaxone,
azithromycin and hydroxychloroquine. COVID-19 infection was confirmed via nasopharyngeal swab four
days after admission.
The patient’s respiratory status continued to decline
and proning was indicated for improved alveolar recruitment. There was hesitation to prone due to the
need for continuous fetal monitoring however the anticipated benefit of proning was determined to outweigh the need for supine positioning to accommodate
fetal monitoring. Despite proning, the patient developed ventilator desynchrony which required heavy sedation and cistacuronium for seven days. Ultimately
a 10-day treatment course with remdesivir was initiated as the patient failed to improve with the aforementioned management.
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On the ninth hospital day, the patient underwent cesarean section with safe delivery of a healthy baby boy
which led to significant improvement in her ability to
oxygenate. The amniotic fluid and placenta tissue culture were negative for COVID-19 infection.
The patient continued to have intermittent febrile
episodes and elevation in procalcitonin which led to
concern for ventilator associated pneumonia with sputum cultures growing methicillin-susceptible Staphylococcus aureus. She completed a seven-day course of
cefepime and vancomycin with repeat chest X-ray indicating improvement of bilateral pulmonary infiltrates.
As she was making significant improvement in her respiratory status, the patient was extubated, however
she required subsequent re-intubation within a few
hours due to increased work of breathing. The patient underwent tracheostomy placement due to difficulty in weaning off mechanical ventilation. This
was attributed to the combination of the patient’s history of myotonic dystrophy, prolonged immobility and
presumed critical care neuromuscular weakness. She
made significant improvement while working with
physical and occupational therapy in regaining her
strength and was slowly weaned off mechanical ventilation. Repeat imaging showed continued improvement of her multifocal pneumonia. Shortly thereafter,
she was transitioned to a tracheostomy collar and decannulated prior to discharge. Of note, she continued

2

ULJRI

A Pregnant Woman with ARDS Due to COVID-19

Figure 2. Heterogenous areas of patchy ground glass opacity and septal thickening bilateral most compatible with an infectious etiology.

to test positive for COVID-19 from the SARS-CoV-2 NP
PCR until the 39th day of her hospital stay. The patient
was able to recover from her illness after 41 days in the
ICU setting and was discharged home in stable condition.

Discussion
This case highlights the rapid progression of COVID-19
infection to ARDS in vulnerable populations. Pregnant
women are known to be at a higher risk of severe illness and higher mortality from viral infections noticeably during pandemics such as Ebola and influenza.[35] Infected women also have an increased incidence of
cesarean delivery and preterm birth. There have been
no reported cases of vertical transmission of COVID19.[6] Being a relatively new disease process, limited
data is available on COVID-19 in pregnant patients.
A comprehensive systematic review published recently
reviewed perinatal outcomes in pregnant patients with
COVID-19. A total of 114 pregnant women were included in the review and the most commonly reported
symptoms were fever (87.5%) and cough (53.8%), followed closely by fatigue (22.5%), myalgia (16.3%) and
dyspnea (11.3%). The majority of studied women had
a cesarean section for various reasons; however, the fetal outcomes were fairly good. Preterm birth (21.3%)
and fetal distress (10.7%) were the most prevalent outcomes. There were no reports of neonatal infection
noted, however the majority of patients were in the
third trimester of pregnancy and further studies are
needed to evaluate neonatal transmission of COVID-
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19.[7] COVID-19 was not detected in the neonate, placenta or amniotic fluid in our case.
Pregnancy is a unique immunologic state in which the
body has to adapt to the fetus—especially acting as a
foreign body—with a resulting increased susceptibility to a variety of infections. The progressive uterine distention during pregnancy is the major cause
for chest wall and lung volume changes. Pregnancyrelated reduction in functional residual capacity combined with increase in oxygen consumption lowers the
oxygen reserve of the mother.[8] This could explain the
significant improvement in oxygenation in our case after undergoing cesarean delivery. There is also evidence showing improved outcomes using higher positive end-expiratory pressure and manual prone positioning, which were utilized in our patient.[9]
The immune system plays an important role in regulation of normal and pathologic states of pregnancy.
Some pro-inflammatory cytokines, namely TNF-a, IL1b and IL-6, IL-10 and regulatory T cells (T reg), have
recently been found to have immunosuppressive properties in the setting of pregnancy, appearing to play a
critical role in both immune stimulatory and counter
regulatory functions. It has been shown in COVID19 infections that IL-6,IL-10, and TNF-a increase the
expression of programmed cell death marker-1 (PD-1)
causing cell death and severe disease, which eventually can be used as prognostic factors in stratification of
disease severity and possibly change management.[10]
In our case, the use of two immunomodulator agents
(hydroxychloroquine and azithromycin) may have ex-
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the persistence of viral carriage for over a month which
could have been detrimental. It is unknown if remdesivir had any impact on this patient’s clinical outcome.
The delivery of the baby appears to have been the main
contributing factor to improvement in oxygenation.
Severe COVID-19 has been associated with a coagulopathic state with elevated D-Dimer and fibrinogen
levels.[11] Pregnancy-related hypercoagulability is an
adaptive mechanism to prevent post-partum hemorrhage. Fibrinogen and thrombin levels are noted to increase up to three times in pregnancy, while protein S,
an anticoagulant factor, decreases. Prolonged bed rest
during pregnancy adds to the venous stasis and hypercoagulable state in pregnancy.[12] The hypercoagulable state of pregnancy plus the pro-thrombotic state
of COVID-19 due to endothelial damage may explain
some of the worse outcomes during pregnancy.
Specific treatment protocols for COVID-19 in pregnancy with the administration of hydroxychloroquine,
azithromycin have shown that there is no significant
increased risk for malformations, intrauterine death,
preterm delivery or low birth weight. There is no sub-
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stantial evidence regarding remdesivir in pregnancy,
however in this particular case, these treatments were
administered in hope of changing the patient’s outcome and possibly shorten disease. It is difficult to determine whether this disease responded to these medications as our patient continued to test positive for over
four weeks while in the ICU or was this a natural course
of the disease itself.
In conclusion, our patient’s clinical course was likely
prolonged due to complications from her type A blood,
type 1 muscular dystrophy, worsening immunosuppression due to immunomodulatory agents, and pregnancy. Conversely, favorable factors included supportive critical care, timely cesarean delivery which improved her respiratory function and thromboprophylaxis. It is still unclear if any of the medical treatments used had any benefit as further larger studies
are needed to establish this definitively. It is also unclear if any of the medical treatments had any effect on
viral shedding as the patient continued to test positive
for four weeks following initial testing. Of the positive contributing factors, it was felt that supportive care
had the most significant impact on the patient’s eventual positive outcome.
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